Memel Biotech is a pioneering Lithuanian company that specializes in providing comprehensive Contract Development and Manufacturing Organization (CDMO) services tailored to the specific needs of Advanced Therapy Medicinal Products (ATMPs) development. We offer GMP-compliant infrastructure, encompassing cutting-edge facilities and a globally diverse team of experts. With a focus on precision medicine research, drug development, and commercialization, we are a trusted partner for advancing ATMPs from concept to clinical reality.